^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
GSK2606414
i
Other names: GSK2606414, GSK414, GSK-2606414, GSK-414, GSK 2606414, GSK 414
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Dartmouth College, GSK, Institute of Cancer Research
Drug class:
RIPK1 inhibitor, PERK inhibitor
Related drugs:
